Valirx plc (VAL) ORD GBP0.001
- Add to watchlist
- Create an alert
- This stock can be held in a
3.63p
3.50p
14.75p
£4.57 million
3.63p
3.30p
3.45p
n/a
0.00p (0.00%) Previous:
0.00p
3,453,641
n/a
15,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue (£m) | n/a | n/a |
Profit before tax (£m) | (2.60) | (1.68) |
Adjusted EPS (p): | (3.06) | (2.34) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
ValiRx inks deal with Dundee Drug Discovery Unit
12 February 2024 12:59
-
ValiRx enters option deal with Ambrose Healthcare
5 December 2023 15:08
-
ValiRx enters partnership with StingRay Bio
10 November 2023 10:32
-
Evaluation Agreement with Imperial College London
21 March 2024 07:00
-
Board Re-structuring and update on requisition
19 March 2024 07:00
-
Shareholder Requisition Notice
4 March 2024 17:47
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.